US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 21, 2025 (17 months ago)

BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations; potential temperature excursions due to transit delays

What was recalled

BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.

Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
NDC code
49401-102-01
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0540-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.